Law360 (May 12, 2020, 8:01 PM EDT) — Drugmakers caught up in the multidistrict litigation over heartburn medication Zantac told a Florida federal court Tuesday the lawsuits are “based on a series of mights and maybes,” saying there’s no evidence of a causal link between the drug and cancer.
In an initial conference before U.S. District Judge Robin L. Rosenberg, the defendants said the science just isn’t there to link Zantac, and its generic equivalent ranitidine, with the many types of cancer claimed by the plaintiffs.
“The law is supposed to lag science,” Anand Agneshwar, who represents drugmaker Sanofi SA and laid out the case for the defendants. “It’s…
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!